Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.

FDA promotes safe use of pain products

The Food and Drug Administration launched a national education campaign to promote safer use of over-the-counter pain relief products, particularly those containing acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen, naproxen sodium, and ketoprofen.

Pw 13433 Rules Regs1

Although widely used, misuse can be harmful. FDA estimates that 56ꯠ emergency room visits and 100 deaths a year are due to acetaminophen overdose. FDA is urging consumers to read labels carefully and follow the directions.

FDA noted that in September 2002 its Non-Prescription Drugs Advisory Committee recommended labeling changes for certain OTC drugs, including acetaminophen and NSAIDs, to better inform consumers about the ingredients in the products and possible side effects from improper use. FDA said it will consider labeling changes and is reviewing changes that better reflect the latest scientific thinking.

2024 PACK EXPO Innovations Reports
Exclusive access: Packaging World editor-curated reports revealing PACK EXPO's most groundbreaking technologies across food, healthcare, and machinery sectors. Each report features truly innovative solutions selected from hundreds of exhibitors by our expert team. Transform your operations with just one click.
Access Now
2024 PACK EXPO Innovations Reports
Break out of the ordinary: see what’s new in packaging & processing!
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this September to experience a breakthrough in packaging and processing.
REGISTER NOW AND SAVE
Break out of the ordinary: see what’s new in packaging & processing!